T Cell News and Research

Latest T Cell News and Research

Researchers use Doppler to look inside living cells, track their metabolic activity

Doppler radar improves lives by peeking inside air masses to predict the weather. A Purdue University team is using similar technology to look inside living cells, introducing a method to detect pathogens and treat infections in ways that scientists never have before.

26 Feb 2021

Programmed magnetic nanobeads rapidly diagnose COVID-19

COVID-19 can be diagnosed in 55 minutes or less with the help of programmed magnetic nanobeads and a diagnostic tool that plugs into an off-the-shelf cell phone, according to Rice University engineers.

26 Feb 2021

New study aims to improve anti-cancer drug response predictions across cancer types

The goal of "precision oncology" is to be able to tailor treatments to each individual patient based on their cancer's unique molecular fingerprints.

26 Feb 2021

Researchers identify cells responsible for maintenance and regeneration of liver

While the amazing regenerative power of the liver has been known since ancient times, the cells responsible for maintaining and replenishing the liver have remained a mystery.

26 Feb 2021

New approach harnesses disease-causing proteins to combat cancer

Over many decades now, traditional drug discovery methods have steadily improved at keeping diseases at bay and cancer in remission. And for the most part, it's worked well.

26 Feb 2021

Study shows why SARS-CoV-2 is more infectious than SARS-CoV-1

Coronavirus outbreaks have occurred periodically, but none have been as devastating as the COVID-19 pandemic.

26 Feb 2021

New method helps study the effects of receptor clustering in living cells

Our body consists of 100 trillion cells that communicate with each other, receive signals from the outside world and react to them.

26 Feb 2021

Antibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl

The first instance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in Austria was observed in the Ski resort Ischgl in early March 2020. Later, the virus spread across Austria and other countries in Northern Europe.

25 Feb 2021

Pre-existing cross-reactive HCoV antibodies could protect against SARS-CoV-2

A team of researchers from Spain and Canada recently characterized the antibody kinetics and neutralization capacity at 4 cross-sectional surveys between March and October 2020 and determined the seroprevalence in the same cohort of healthcare workers.

25 Feb 2021

Microbes could predict fatal outcomes in ventilated COVID-19 patients

The study "Microbial signatures in the lower airways of mechanically ventilated COVID19 patients associated with poor clinical outcome" is available as a preprint on the medRxiv* server, while the article undergoes peer review.

25 Feb 2021

Scientists receive grant to investigate tumor development within a natural environment

Unlike many of us during the COVID-19 pandemic, biological cells are not isolated from the outside world. Chemical variations, intercellular activity, and other microenvironmental factors impact cell survival.

25 Feb 2021

CRISPR screen identifies clinically approved immunosuppressants that could treat coronavirus infections

Researchers in Switzerland and Germany have identified host cell factors required for coronavirus replication that could serve as targets for treatment with clinically-approved drugs.

25 Feb 2021

Study pinpoints potential transmission advantage of SARS-CoV-2 variant B.1.1.7

Researchers in the UK have shown that the increased transmissibility of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage B.1.1.7 that emerged in the UK during the coronavirus disease 2019 (COVID-19) pandemic does not appear to be the result of increased viral replication or immune escape.

25 Feb 2021

Repetitive compression of limbs may improve recovery from the most deadly stroke

Scientists want to know more about how an inexpensive, low-risk treatment may improve recovery from the most deadly type of stroke.

25 Feb 2021

SARS-CoV-2 ORF7a mutation limits host immune suppression, finds study

Researchers have identified a high variability in the C-terminal end of ORF7a in SARS-CoV-2 sequences collected from around the globe. They noted that mutations result in a defective suppression of interferon and lowered replication rate.

25 Feb 2021

SNX-5422 could make an effective COVID-19 prophylactic, says study

SNX-5422 is a heat shock protein 90 (Hsp90) inhibitor currently undergoing clinical trials as a cancer therapeutic. A recent study examines the applicability of repurposing the drug towards severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication inhibition.

25 Feb 2021

T Cell News and Research

Latest T Cell News and Research

Researchers use Doppler to look inside living cells, track their metabolic activity

Programmed magnetic nanobeads rapidly diagnose COVID-19

New study aims to improve anti-cancer drug response predictions across cancer types

Researchers identify cells responsible for maintenance and regeneration of liver

New approach harnesses disease-causing proteins to combat cancer

Study shows why SARS-CoV-2 is more infectious than SARS-CoV-1

New method helps study the effects of receptor clustering in living cells

Antibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl

Pre-existing cross-reactive HCoV antibodies could protect against SARS-CoV-2

Microbes could predict fatal outcomes in ventilated COVID-19 patients

Scientists receive grant to investigate tumor development within a natural environment

CRISPR screen identifies clinically approved immunosuppressants that could treat coronavirus infections

Study pinpoints potential transmission advantage of SARS-CoV-2 variant B.1.1.7

Repetitive compression of limbs may improve recovery from the most deadly stroke

SARS-CoV-2 ORF7a mutation limits host immune suppression, finds study

SNX-5422 could make an effective COVID-19 prophylactic, says study

Research shows effective strategy to target the SARS-CoV-2 spike protein

Study reveals molecular details of SARS-CoV-2 interactions with human cells

Study reports lasting immune response in convalescent COVID-19 patients

Neuroinvasiveness of SARS-CoV-2 shown by viral RNA and inflammation in the brain

Immunology eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in